Alpha 1-antitrypsin deficiency

1. What clinical findings are likely in R.S. as a consequence of his COPD B? There are multiple types of chronic obstructive pulmonary disease (COPD), COPD “characterized by chronic and recurrent obstruction of airflow in the pulmonary airways (Porth & Matfin, 2009). The recurrent obstruction makes it difficult for a person to breath overtime this problem occurs in the lower respiratory tract. COPD compromises the flow of air in the lungs this causes less oxygen that is being circulated…

including environmental toxins, alcohol abuse, nonalcoholic fatty liver disease, hereditary hemochromatosis or alpha-1 antitrypsin deficiency among others. There has been significant increase in the rate of HBV- and HCV-related HCC[1]. Liver cirrhosis is the most important pre-malignant lesion of HCC, but HCC can occur in non-cirrhotic patients too, with the predominant risk factor being HBV infection[1]. In non-cirrhotic patients, occurrence of HCC is established to have been mostly because of…

consistent and long-term exposure to irritants. Some causes are tobacco smoke, marijuana smoke, pollution of the air, and manufactured fumes. Patients can also rarely inherit a deficiency of a protein that works to protect the elastic structures in the lungs. This is a specific kind of emphysema and is called alpha-1 antitrypsin deficiency emphysema. This type of emphysema is very rare and a interesting case when it is known. Patients can have emphysema for a long time without any idea.…

(American Cancer Society, 2014). Some patients that has certain inherited metabolic disease is at a higher risk of developing liver cancer although this is rare. These diseases include hemochromatosis, Wilson’s disease, tyrosinaemia, alpha-1 antitrypsin deficiency, and glycogen storage disease (American Cancer Society, 2014). These diseases could cause liver damage that leads to liver cirrhosis and eventually liver…

soon enough. Physicians should do a comprehensive evaluation to determine if COPD is the cause of problems. Some common test include a chest x-ray, arterial blood gas analysis, CT scan, lung function test, and laboratory test to determine if AAt deficiency exist. COPD is treatable and can be managed through medication or therapy. Common therapy programs for COPD is smoking cessation to help individuals stop smoking to prevent the risk of COPD getting worse. Individuals may need oxygen therapy…

“COPD kills 2.5 million people a year, according to World Health Organization estimates. It is currently the fifth leading cause of death in high-income countries like the U.S”(L. Chang,MD) COPD is a lung diseases that is causes by an obstruction in the lung that make it difficult to breathe. COPD is weakens the airways and causes breathing problems this work as the air that is breathe goes down the windpipe into tubes in the lungs the bronchial tubes. The bronchial tubes branch into thousands…

According to the American Lung Association, 23 million people have asthma, 13.6 million people have COPD, and an equal number still have not been diagnosed. Most have heard of asthma, COPD, bronchitis, and pneumonia. For some, these are very common lung issues; but have you ever heard of bronchiectasis? According to the American Lung Association, bronchiectasis is a chronic condition where the walls of the bronchi are thickened from inflammation and infection. Bronchiectasis is divided into two…

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease process that includes emphysema, chronic bronchitis, and in some cases asthma. COPD is the sixth leading cause of death in the United States (Reid, 2014). This disease is a public health problem that is not only preventable but treatable. It is important to know about the illness, symptoms, standard inhaled medication and explore a newer long-acting muscarinic antagonist bronchodilator as Global initiative for Chronic…

A COPD case study will be assessed and discussed. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 guidelines will be analyzed and applied to the case study presented below. Patient monitoring, education strategies, and clinical end point of the chosen drug therapy will be identified. Sample dosages form, route, and frequency of administration based on patients’ health status will be justified. Finally, the efficacy of complementary and alternative medicine (CAM) will be…

COPD is a disease characterized by chronic airflow limitation that is not fully reversible. The airflow limitation in COPD is usually progressive and is associated with an inflammatory response of the lungs (Haggerty, 2013). The pathological changes that indicate COPD include an increase in mucus producing cells, chronic inflammation in different parts of the lung, and structural changes that result from a persistent cycle of destruction and repair. Many parts of the lungs are affected,…